Cyclo Therapeutics (CYTH) Prices 1.95M Share Offering at $6/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil prices hit fresh 6-week highs on renewed Middle East tensions
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Cyclo Therapeutics (CYTH) Announces Proposed Stock Offering, Size not Disclosed
November 16, 2021 4:27 PM ESTCyclo Therapeutics, Inc. (Nasdaq: CYTH, CYTHW), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or... More
Cyclo Therapeutics (CYTH) Submits IND to U.S. FDA to Advance Trappsol Cyclo in Phase 2 Study for Treatment of Alzheimer's Disease
November 16, 2021 8:06 AM ESTCyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced it has submitted its initial investigational new drug (IND) application with the... More
